BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1536717)

  • 21. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
    Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid restoration of natural killer activity following treatment with 2-chlorodeoxyadenosine in 22 patients with hairy-cell leukemia.
    Lauria F; Rondelli D; Raspadori D; Benfenati D; Tura S
    Eur J Haematol; 1994 Jan; 52(1):16-20. PubMed ID: 7905425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of natural killer cell activity in hairy cell leukemia patients and partial restoration with interleukin-2.
    Hooper WC; Barth RF; Shah NT
    Cancer; 1986 Mar; 57(5):988-93. PubMed ID: 3484663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase of HLA-DR-positive natural killer cells in peripheral blood from patients with IgA nephropathy.
    Yano N; Endoh M; Nomoto Y; Sakai H; Rifai A
    Hum Immunol; 1996 Aug; 49(1):64-70. PubMed ID: 8839777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunophenotyping of leukemic cells in the diagnosis of hairy cell leukemia].
    Gotić M; Kraguljac N; RolovićZ ; Radosević N; Bosković D
    Srp Arh Celok Lek; 2000; 128(5-6):157-64. PubMed ID: 11089415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased NK activity in hairy cell leukemia (HCL): an analysis at the cellular level.
    Fontana L; De Rossi G; De Sanctis G; Ensoli F; Lopez M; Annino L; Mandelli F
    Blut; 1986 Aug; 53(2):107-13. PubMed ID: 3730622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells.
    Scott-Algara D; Vuillier F; Cayota A; Dighiero G
    Clin Exp Immunol; 1992 Nov; 90(2):181-7. PubMed ID: 1424272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone.
    Hayakawa K; Salmeron MA; Kornbluth J; Bucana C; Itoh K
    J Immunol; 1991 Apr; 146(7):2453-60. PubMed ID: 1900882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia.
    Ruco LP; Procopio A; Maccallini V; Calogero A; Uccini S; Annino L; Mandelli F; Baroni CD
    Blood; 1983 Jun; 61(6):1132-7. PubMed ID: 6220750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
    Goodier MR; Londei M
    J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α.
    Riley CH; Hansen M; Brimnes MK; Hasselbalch HC; Bjerrum OW; Straten PT; Svane IM; Jensen MK
    Eur J Haematol; 2015 Mar; 94(3):227-34. PubMed ID: 25082025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-interferon and lymphokine-activated killer cells in hairy cell leukemia.
    Griffiths SD; Cawley JC
    Leukemia; 1988 Jun; 2(6):377-81. PubMed ID: 3374170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-21 differentially affects human natural killer cell subsets.
    Wendt K; Wilk E; Buyny S; Schmidt RE; Jacobs R
    Immunology; 2007 Dec; 122(4):486-95. PubMed ID: 17635612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of general anesthesia and surgery on basal and interferon stimulated natural killer cell activity of humans.
    Kutza J; Gratz I; Afshar M; Murasko DM
    Anesth Analg; 1997 Oct; 85(4):918-23. PubMed ID: 9322480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer-mediated lysis of some but not all HSV-1- or VSV-infected targets requires the participation of HLA-DR-positive accessory cells.
    Howell DM; Fitzgerald-Bocarsly P
    Immunology; 1991 Mar; 72(3):443-7. PubMed ID: 1851136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometric study on phagocyte function and determination of in vitro natural killer (NK) cell cytotoxicity in hairy cell leukaemia (HCL). Comparison with values obtained following post-traumatic splenectomy (SP).
    Demeter J; Mihalik R; Pálóczi K; Benczur M
    Acta Paediatr Hung; 1988-1989; 29(1-2):219-20. PubMed ID: 3255408
    [No Abstract]   [Full Text] [Related]  

  • 37. Interferon alpha-2 for hairy cell leukemia: evidence for induction of RNA synthesis in hairy cells and failure to correlate enhancement of natural killer cells with elimination of hairy cells.
    Schwarzmeier JD; Schwabe M; Prischl F; Wagner L; Lion T; Micksche M; Köller U
    Eur J Haematol; 1987 Nov; 39(5):418-25. PubMed ID: 3691760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-alpha-dependent and -independent participation of accessory cells in natural killer cell-mediated lysis of HSV-1-infected fibroblasts.
    Feldman M; Howell D; Fitzgerald-Bocarsly P
    J Leukoc Biol; 1992 Nov; 52(5):473-82. PubMed ID: 1331279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
    Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
    J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural killer cell subpopulations in putative resistant individuals and patients with active Mycobacterium tuberculosis infection.
    Barcelos W; Sathler-Avelar R; Martins-Filho OA; Carvalho BN; Guimarães TM; Miranda SS; Andrade HM; Oliveira MH; Toledo VP
    Scand J Immunol; 2008 Jul; 68(1):92-102. PubMed ID: 18484953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.